Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 20/20 | 1.00 |
| ▸ | MMP13 | P45452 | 20/20 | 1.00 |
| ▸ | MMP1 | P03956 | 19/20 | 1.00 |
| ▸ | ADAM17 | P78536 | 17/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7348749 | 1.00 | MMP9 (1.00) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL7320048 | 0.91 | MMP1 (0.84) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL7318146 | 0.88 | MMP1 (0.78) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL7554630 | 0.88 | MMP1 (0.78) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL7315614 | 0.84 | MMP9 (0.86) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL7348743 | 0.82 | MMP13 (0.70) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL6852400 | 0.81 | MMP9 (1.00) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL7325385 | 0.80 | MMP9 (1.00) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL27563881 | 0.79 | MMP1 (0.65) | MMP9MMP13MMP1ADAM17 | |
| SCHEMBL27510260 | 0.76 | MMP1 (0.61) | MMP9MMP13MMP1ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-0977756-A1 | PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION | Pfizer Limited (GB) | 2000-02-09 | — | — | EP | disclosed |
| EP-0938471-A1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | American Cyanamid Company (US) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998049166-A1 | PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION | PFIZER LIMITED (GB) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998016503-A2 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |